MYMX
MYMETICS CORP by Mymetics Corp. (MYMX)
$00
About MYMETICS CORP by Mymetics Corp. (MYMX)
Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. Its vaccine pipeline includes Influenza and RSV, HIV/AIDS, Malaria, Immunotheraphy, and COVID-19. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
8
P/E ratio
--
MYMETICS CORP by Mymetics Corp. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
8
P/E ratio
--